US-based Dieter Weinand is the former CEO of Bayer Pharma with more than 25 years of experience as a senior business leader in the pharmaceutical industryThe appointment comes as AstriVax Therapeutics ...

Leuven, Belgium, June 12, 2025 - AstriVax Therapeutics NV, a clinical stage immunotherapy company developing novel treatments for chronic infections based on its proprietary Launch-iT technology, ...

US-based Dieter Weinand is the former CEO of Bayer Pharma with more than 25 years of experience as a senior business leader in the pharmaceutical industryThe appointment comes as AstriVax ...

Mr. Weinand is currently a member of the Board of Coya Therapeutics and Replimune, Chairman of the Board of Confo Therapeutics, and Executive Chairman of the Board of Mnemo Therapeutics.

Belgium's Confo Therapeutics, another company hoping to tap into the mad rush in the pharma industry for drugs for weight loss, made around €60 million (around $65 million) from its Series B ...

US-based Dieter Weinand is the former CEO of Bayer Pharma with more than 25 years of experience as a senior business leader in the pharmaceutical industryThe appointment comes as AstriVax Therapeutics ...

Leuven, Belgium, June 12, 2025 – AstriVax Therapeutics NV, a clinical stage immunotherapy company developing novel treatments for chronic infections based on its proprietary Launch-iT technology, ...